chronic kidney disease

Ozempic receives FDA nod for treating chronic kidney disease

F.D.A. Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

CNN on MSN · 2d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

infectiousdiseaseadvisor.com · 2h

Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Frontiers6h

Modifiable Risk Factors for Chronic Kidney Disease Progression

Chronic kidney disease (CKD) is a growing global health concern, significantly contributing to morbidity and mortality rates worldwide. Characterized by a ...

BioSpace2d

Lilly Cuts Mid-stage Relaxin Study in Chronic Kidney Disease for ‘Lack of Foreseeable Clinical Benefit’

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Ozempic receives FDA nod for treating chronic kidney disease

Trending now

Related topics